1.
Charcot JM. Sur quelaques arthropathies qui paraissent depender d’une lesion du cerveau ou de la moele epiniere. Arch Des Physiol Norm et Path. 1868;1:161–71.
2.
Sanders LJ, Frykberg RG. The charcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991. p. 325–35.
3.
Kelly M. John Kearsley Mitchell and the neurogenic theory of arthritis. J Hist Med. 1965;20:151–7.
4.
Armstrong DG, Todd WF, Lavery LA, Harkless LB. The natural history of acute Charcot’s arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997;14:357–63.
PubMed
5.
Mitchell JK. On a new practice in acute and chronic rheumatism. Am J Med Sci. 1831;8:55.
6.
Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307–12.
7.
Bailey CC, Root HF. Neuropathic foot lesions in diabetes mellitus. N Engl J Med. 1947;236:397.
8.
Sinha S, Munichoodapa CS, Kozak GP. Neuroarthropathy (Charcot joints) in diabetes mellitus. Medicine. 1972;51:191–210.
PubMed
9.
Frykberg RG, Kozak GP. Neuropathic arthropathy in the diabetic foot. Am Fam Physician. 1978;17:105.
PubMed
10.
Sanders LJ, Frykberg RG. Charcot neuroarthropathy of the foot. In: JH B, MA P, editors. Levin and O’Neals The Diabetic Foot. 6th ed. St Louis: Mosby; 2001.
11.
Cofield RH, Morrison MJ, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle. 1983;4:15–22.
PubMed
12.
Lavery LA, Armstrong DG, Wunderlich RP, Boulton AJM, Tredwell JL. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–8.
PubMed
13.
Frykberg RG, Kozak GP. The diabetic Charcot foot. In: Kozak GP, Campbell DR, Frykberg RG, Cavanagh PR, editors. Management of diabetic foot problems. 2nd ed. Philadelphia: WB Saunders; 1995.
14.
Frykberg RG. Charcot foot: an update on pathogenesis and management. In: Boulton AJM, Connor H, Cavanagh PR, editors. The foot in diabetes. 3rd ed. Chichester, UK: Wiley; 2000.
15.
Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21(11):1243–6.
PubMed
16.
Sohn MW, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009;32(5):816–21.
PubMed
17.
van Baal J, Hubbard R, Game F, Jeffcoate W. Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care. 2010;33(5):1086–9.
PubMed
18.
Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg. 2000;39(5 Suppl):S1–60.
PubMed
19.
Bevilacqua NJ, Bowling F, Armstrong DG. The hatural history of Charcot neuroarthropathy. In: Frykberg RG, editor. The diabetic charcot foot: principals and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 13–28.
20.
Brower AC, Allman RM. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology. 1981;139:349–54.
PubMed
21.
Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med. 2000;17(4):253–8.
PubMed
22.
Boulton AJ. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47(8):1343–53.
PubMed
23.
Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47(3):457–63.
PubMed
24.
Edelman SV, Kosofsky EM, Paul RA, Kozak GP. Neuro-osteoarthropathy (Charcot’s joint) in diabetes mellitus following revascularization surgery. Three case reports and a review of the literature. Arch Intern Med. 1987;147(8):1504–8.
PubMed
25.
Banks AS, McGlamry ED. Charcot foot. J Am Podiatr Med Assoc. 1989;79:213–7.
PubMed
26.
Gough A, Abraha H, Li F, et al. Measurement of markers of osteoclast activity in patients with acute and chronic diabetic Charcot arthropathy. Diabet Med. 1997;14(7):527–31.
PubMed
27.
Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18(1):34–8.
PubMed
28.
Jirkovska A, Kasalicky P, Boucek P, Hosova J, Skibova J. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med. 2001;18(6):495–500.
PubMed
29.
Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085–96.
PubMed
30.
Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg. 2004;43(2):87–92.
PubMed
31.
Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br. 2004;86(3):378–83.
PubMed
32.
Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44(11):2032–7.
PubMed
33.
Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Diabetologia. 2004;47(9):1488–92.
PubMed
34.
Jeffcoate WJ, Game FL. New theories on the causes of the Charcot foot in diabetes. In: Frykberg RG, editor. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 29–44.
35.
Eichenholtz SN. Charcot joints. Springfield: Charles C. Thomas; 1966.
36.
Schon LC, Marks RM. The management of neuroarthropathic fracture-dislocations in the diabetic patient. Orthop Clin North Am. 1995;26(2):375–92.
PubMed
37.
Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38(1):34–40.
PubMed
38.
Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot’s neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc. 2002;92(4):210–20.
PubMed
39.
Harris JR, Brand PW. Patterns of disintegration of the tarsus in the anesthetic foot. J Bone Joint Surg. 1966;48B(1):4–16.
40.
Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominences in diabetic Charcot feet. Clin Orthop Relat Res. 1993;296:21–6.
PubMed
41.
Schon LC, Weinfeld SB, Horton GA, Resch S. Radiographic and clinical classification of acquired midtarsus deformities. Foot Ankle Int. 1998;19(6):394–404.
PubMed
42.
Frykberg RG, Rogers LC. Classification of the Charcot foot. In: Frykberg RG, editor. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 55–64.
43.
Rogers LC, Bevilacqua NJ. The diagnosis of Charcot foot. Clin Podiatr Med Surg. 2008;25(1):43–51.
PubMed
44.
Frykberg RG. Charcot arthropathy: pathogenesis and management. Wounds. 2000;12(6 Suppl B):35B–42.
45.
Newman JH. Spontaneous dislocation in diabetic neuropathy. A report of six cases. J Bone Joint Surg Br. 1979;61(4):484–8.
PubMed
46.
Lesko P, Maurer RC. Talonavicular dislocations and midfoot arthropathy in neuropathic diabetic feet. Natural course and principles of treatment. Clin Orthop Relat Res. 1989;240:226–31.
PubMed
47.
Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23(6):796–800.
PubMed
48.
El-Khoury GY, Kathol MH. Neuropathic fractures in patients with diabetes mellitus. Radiology. 1980;134(2):313–6.
PubMed
49.
Kathol MH, el-Khoury GY, Moore TE, Marsh JL. Calcaneal insufficiency avulsion fractures in patients with diabetes mellitus. Radiology. 1991;180(3):725–9.
PubMed
50.
Petrova NL, Foster AV, Edmonds ME. Difference in presentation of charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27(5):1235–6.
PubMed
51.
Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg. 2002;91(2):195–201.
PubMed
52.
McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of Charcot’s arthropathy to contact casting: assessment by quantitative techniques. Diabetologia. 2000;43(4):481–4.
PubMed
53.
Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26(1):46–63.
PubMed
54.
Sella EJ, Grosser DM. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg. 2003;20(4):729–40.
PubMed
55.
Wukich DK, Belczyk RJ. Silent neuropathic bone injuries and dislocations – stage 0. In: Frykberg RG, editor. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 117–30.
56.
Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. 1989;149(10):2262–6.
PubMed
57.
Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am. 2004;42(1):61–71. vi.
PubMed
58.
Palestro CJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99 m sulfur colloid scintigraphy. J Nucl Med. 1998;39(2):346–50.
PubMed
59.
Rogers LC, Bevilacqua NJ. Imaging of the Charcot foot. Clin Podiatr Med Surg. 2008;25(2):263–74.
PubMed
60.
Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35(4):280–3.
PubMed
61.
Seabold JE, Flickinger FW, Kao SC, et al. Indium-111-leukocyte/technetium-99 m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med. 1990;31(5):549–56.
PubMed
62.
Schauwecker DS, Park HM, Burt RW, Mock BH, Wellman HN. Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med. 1988;29(10):1651–5.
PubMed
63.
Johnson JE, Kennedy EJ, Shereff MJ, Patel NC, Collier BD. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int. 1996;17(1):10–6.
PubMed
64.
Blume PA, Dey HM, Daley LJ, Arrighi JA, Soufer R, Gorecki GA. Diagnosis of pedal osteomyelitis with Tc-99 m HMPAO labeled leukocytes. J Foot Ankle Surg. 1997;36(2):120–6. discussion 160.
PubMed
65.
Croll SD, Nicholas GG, Osborne MA, Wasser TE, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. J Vasc Surg. 1996;24(2):266–70.
PubMed
66.
Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004;25(12):890–5.
PubMed
67.
Pinzur MS, Shields N, Trepman E, Dawson P, Evans A. Current practice patterns in the treatment of Charcot foot. Foot Ankle Int. 2000;21(11):916–20.
PubMed
68.
Frykberg RG, Eneroth M. Principles of conservative management. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 93–116.
69.
Caputo GM, Ulbrecht J, Cavanagh PR, Juliano P. The Charcot foot in diabetes: six key points. Am Fam Physician. 1998;57(11):2705–10.
PubMed
70.
Pinzur MS, Sage R, Stuck R, Kaminsky S, Zmuda A. A treatment algorithm for neuropathic (Charcot) midfoot deformity. Foot Ankle. 1993;14(4):189–97.
PubMed
71.
Myerson MS, Henderson MR, Saxby T, Wilson-Short K. Management of midfoot diabetic neuroarthropathy. Foot Ankle. 1994;15(5):233–41.
PubMed
72.
Pinzur M. Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int. 2004;25(8):545–9.
PubMed
73.
Morgan JM, Biehl 3rd WC, Wagner Jr FW. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop Relat Res. 1993;296:58–63.
PubMed
74.
Armstrong DG, Short B, Nixon BP, Boulton AJM. Technique for fabrication of an “instant” total contact cast for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc. 2002;92:405–8.
PubMed
75.
Saltzman CL, Johnson KA, Goldstein RH, Donnelly RE. The patellar tendon-bearing brace as treatment for neurotrophic arthropathy: a dynamic force monitoring study. Foot Ankle. 1992;13:14–21.
PubMed
76.
Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994;11(1):28–31.
PubMed
77.
Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004;43(5):285–9.
PubMed
78.
Pitocco D, Ruotolo V, Caputo S, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28(5):1214–5.
PubMed
79.
Bem R, Jirkovska A, Fejfarova V, Skibova J, Jude EB. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care. 2006;29(6):1392–4.
PubMed
80.
Bier RR, Estersohn HS. A new treatment for Charcot joint in the diabetic foot. J Am Podiatr Med Assoc. 1987;77(2):63–9.
PubMed
81.
Hanft JR, Goggin JP, Landsman A, Surprenant M. The role of combined magnetic field bone growth stimulation as an adjunct in the treatment of neuroarthropathy/Charcot joint: an expanded pilot study. J Foot Ankle Surg. 1998;37(6):510–5. discussion 550–511.
PubMed
82.
Grady JF, O’Connor KJ, Axe TM, Zager EJ, Dennis LM, Brenner LA. Use of electrostimulation in the treatment of diabetic neuroarthropathy. J Am Podiatr Med Assoc. 2000;90(6):287–94.
PubMed
83.
Strauss E, Gonya G. Adjunct low intensity ultrasound in Charcot neuroarthropathy. Clin Orthop Relat Res. 1998;349:132–8.
PubMed
84.
Hockenbury RT, Gruttadauria M, McKinney I. Use of implantable bone growth stimulation in Charcot ankle arthrodesis. Foot Ankle Int. 2007;28(9):971–6.
PubMed
85.
Papa J, Myerson M, Girard P. Salvage with arthrodesis in intractable diabetic neuropathic arthropathy of the foot and ankle. J Bone Joint Surg Am. 1993;75A(7):1056–66.
86.
Pinzur MS. Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot Ankle Int. 1999;20(9):564–7.
PubMed
87.
Myerson MS, Alvarez RG, Lam PW. Tibiocalcaneal arthrodesis for the management of severe ankle and hindfoot deformities. Foot Ankle Int. 2000;21(8):643–50.
PubMed
88.
Steindler A. The tabetic arthropathies. J Am Med Assoc. 1931;96:250.
89.
Samilson RL, Sankaran B, Bersani FA, Smith AD. Orthopedic management of neuropathic joints. Arch Surg. 1959;78:119–21.
90.
Johnson JT. Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am. 1967;49(1):1–30.
PubMed
91.
Heiple KG, Cammarn MR. Diabetic neuroarthropathy with spontaneous peritalar fracture-dislocation. A report of two cases. J Bone Joint Surg Am. 1966;48(6):1177–81.
PubMed
92.
Baravarian B, Van Gils CC. Arthrodesis of the Charcot foot and ankle. Clin Podiatr Med Surg. 2004;21(2):271–89.
PubMed
93.
Leventen EO. Charcot foot – a technique for treatment of chronic plantar ulcer by saucerization and primary closure. Foot Ankle. 1986;6(6):295–9.
PubMed
94.
Catanzariti AR, Mendicino R, Haverstock B. Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg. 2000;39(5):291–300.
PubMed
95.
Newman JH. Non-infective disease of the diabetic foot. J Bone Joint Surg Br. 1981;63B(4):593–6.
PubMed
96.
Pinzur MS. Surgical management – history and general principles. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 165–88.
97.
Rosenblum BI, Giurini JM, Miller LB, Chrzan JS, Habershaw GM. Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage. J Foot Ankle Surg. 1997;36(5):360–3.
PubMed
98.
Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot. J Bone Joint Surg Am. 2000;82-A(7):939–50.
PubMed
99.
Wang JC, Le AW, Tsukuda RK. A new technique for Charcot’s foot reconstruction. J Am Podiatr Med Assoc. 2002;92(8):429–36.
PubMed
100.
Jolly GP, Zgonis T, Polyzois V. External fixation in the management of Charcot neuroarthropathy. Clin Podiatr Med Surg. 2003;20(4):741–56.
PubMed
101.
Farber DC, Juliano PJ, Cavanagh PR, Ulbrecht J, Caputo G. Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int. 2002;23(2):130–4.
PubMed
102.
Thompson Jr RC, Clohisy DR. Deformity following fracture in diabetic neuropathic osteoarthropathy. Operative management of adults who have type-I diabetes. J Bone Joint Surg Am. 1993;75(12):1765–73.
PubMed
103.
Marks RM, Parks BG, Schon LC. Midfoot fusion technique for neuroarthropathic feet: biomechanical analysis and rationale. Foot Ankle Int. 1998;19(8):507–10.
PubMed
104.
Cooper PS. Application of external fixators for management of Charcot deformities of the foot and ankle. Semin Vasc Surg. 2003;16(1):67–78.
PubMed
105.
Lamm BM, Paley D. Reduction of neuropathic foot deformity with gradual external fixation distraction and midfoot fusion. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 197–210.
106.
Wukich DK, Zgonis T. Circular external fixation in Charcot neuroarthropathy. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 233–44.
107.
Mendicino RW, Catanzariti AR, Saltrick KR, et al. Tibiotalocalcaneal arthrodesis with retrograde intramedullary nailing. J Foot Ankle Surg. 2004;43(2):82–6.
PubMed
108.
Pinzur MS, Kelikian A. Charcot ankle fusion with a retrograde locked intramedullary nail. Foot Ankle Int. 1997;18(11):699–704.
PubMed
109.
Moore TJ, Prince R, Pochatko D, Smith JW, Fleming S. Retrograde intramedullary nailing for ankle arthrodesis. Foot Ankle Int. 1995;16(7):433–6.
PubMed
110.
Bevilacqua NJ, Rogers LC. Surgical management of charcot midfoot deformities. Clin Podiatr Med Surg. 2008;25(1):81–94.
PubMed
111.
Bevilacqua NJ, Dankert JP, Rogers LC, Armstrong DG. A technique to protect external fixation devices. J Foot Ankle Surg. 2008;47(2):172–4.
PubMed
112.
Rogers LC, Bevilacqua NJ, Frykberg RG, Armstrong DG. Predictors of postoperative complications of Ilizarov external ring fixators in the foot and ankle. J Foot Ankle Surg. 2007;46(5):372–5.
PubMed
113.
Wukich DK, Belczyk RJ, Burns PR, Frykberg RG. Complications encountered with circular ring fixation in persons with diabetes mellitus. Foot Ankle Int. 2008;29(10):994–1000.
PubMed
114.
Clohisy DR, Thompson RC. Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Joint Surg Am. 1988;70A:1192–200.
115.
Eckardt A, Schollner C, Decking J, et al. The impact of Syme amputation in surgical treatment of patients with diabetic foot syndrome and Charcot-neuro-osteoarthropathy. Arch Orthop Trauma Surg. 2004;124(3):145–50.
PubMed
116.
Tan AL, Greenstein A, Jarrett SJ, McGonagle D. Acute neuropathic joint disease: a medical emergency? Diabetes Care. 2005;28(12):2962–4.
PubMed
117.
Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med. 2005;22(12):1707–12.
PubMed